EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Nitrofuran-Warhead-Equipped Spirocyclic Azetidines Show Excellent Activity against Mycobacterium tuberculosis

Kristina Komarova, Lyubov Vinogradova, Alexey Lukin iD, Maxim Zhuravlev, Dmitry Deniskin, Mikhail Chudinov iD, Maxim Gureev iD, Marine Dogonadze, Natalia Zabolotnykh, Tatiana Vinogradova, Anastasia Lavrova, Petr Yablonskiy

Molecules · 2024

DOI: 10.3390/molecules29133071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Kristina Komarova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Lomonosov Institute of Fine Chemical Technologies, MIREA-Russian Technological University, 119454 Moscow, Russia. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Microbial Sensitivity Tests, Azetidines. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of the Russian Federation, Saint Petersburg State Research Institute of Phthisiopulmonology, Russian Federal Academic Leadership Program Priority 2030 at the Immanuel Kant Baltic Federal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of 21 new 7′H-spiro[azetidine-3,5′-furo [3,4-d]pyrimidine]s substituted at the pyrimidine ring second position were synthesized. The compounds showed high antibacterial in vitro activity against M. tuberculosis. Two compounds had lower minimum inhibitory concentrations against Mtb (H37Rv strain) compared with isoniazid. The novel spirocyclic scaffold shows excellent properties for anti-tuberculosis drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAntitubercular AgentsMicrobial Sensitivity TestsAzetidinesNitrofuransSpiro CompoundsStructure-Activity RelationshipMolecular Structure

Stichwörter der Autor:innen

antimycobacterial activitydeazaflavin-dependent nitroreductaseinduced fit dockingnitrofuransspiroazetidinestuberculosis

Substanzen

Antitubercular AgentsAzetidinesNitrofuransSpiro Compounds

Autor:innen und Institutionen

  • Lomonosov Institute of Fine Chemical Technologies, MIREA-Russian Technological University, 119454 Moscow, Russia.
  • Institute of Cytology, Russian Academy of Sciences, Tikhoretsky Ave 4, 194064 Saint Petersburg, Russia.
  • Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, 191036 Saint Petersburg, Russia.
  • Sophya Kovalevskaya North-West Mathematical Research Center, Immanuel Kant Baltic Federal University, 236041 Kaliningrad, Russia.
  • Department of Hospital Surgery, Faculty of Medicine, Saint Petersburg State University, 199034 Saint Petersburg, Russia.

ORCID-Profile: Alexey Lukin, Mikhail Chudinov, Maxim Gureev

Förderung

  • Ministry of Health of the Russian Federation
  • Saint Petersburg State Research Institute of Phthisiopulmonology
  • Russian Federal Academic Leadership Program Priority 2030 at the Immanuel Kant Baltic Federal University

Zitieren

APA

Komarova, K., Vinogradova, L., Lukin, A., Zhuravlev, M., Deniskin, D., Chudinov, M., Gureev, M., Dogonadze, M., Zabolotnykh, N., Vinogradova, T., Lavrova, A., & Yablonskiy, P. (2024). The Nitrofuran-Warhead-Equipped Spirocyclic Azetidines Show Excellent Activity against Mycobacterium tuberculosis. Molecules. https://doi.org/10.3390/molecules29133071

Vancouver

Komarova K, Vinogradova L, Lukin A, Zhuravlev M, Deniskin D, Chudinov M, et al. The Nitrofuran-Warhead-Equipped Spirocyclic Azetidines Show Excellent Activity against Mycobacterium tuberculosis. Molecules. 2024. doi:10.3390/molecules29133071

BibTeX
@article{Komarova2024,
  author = {Komarova, Kristina and Vinogradova, Lyubov and Lukin, Alexey and Zhuravlev, Maxim and Deniskin, Dmitry and Chudinov, Mikhail and Gureev, Maxim and Dogonadze, Marine and Zabolotnykh, Natalia and Vinogradova, Tatiana and Lavrova, Anastasia and Yablonskiy, Petr},
  title = {The Nitrofuran-Warhead-Equipped Spirocyclic Azetidines Show Excellent Activity against Mycobacterium tuberculosis},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29133071}
}
Kostenlos starten →